LEVETIRACETAM TEVA ® 250 MG

国家: 以色列

语言: 英文

来源: Ministry of Health

有效成分:

LEVETIRACETAM 250 MG

可用日期:

TEVA PHARMACEUTICAL INDUST.LTD

ATC代码:

N03AX14

药物剂型:

TABLETS

给药途径:

PER OS

厂商:

TEVA PHARMACEUTICAL INDUSTRIES LTD

治疗组:

LEVETIRACETAM

疗效迹象:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

授权日期:

2009-09-01